Literature DB >> 15780716

Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin.

Franziska Roth-Walter1, Isabella Schöll, Eva Untersmayr, Adolf Ellinger, George Boltz-Nitulescu, Otto Scheiner, Franz Gabor, Erika Jensen-Jarolim.   

Abstract

Murine intestinal M-cells express alpha-L-fucose residues. We constructed alpha-L-fucose-targeting particles for oral immunotherapy of IgE-mediated allergy. Poly(D,L-lactic-co-glycolic acid)-microspheres were loaded with birch pollen allergens, and functionalised with the alpha-L-fucose specific Aleuria aurantia lectin (AAL). The AAL-microspheres had a size of 1-3 microm, protected the entrapped allergens from gastric degradation and released 46.6+/-1.3% allergen over 21 days in vitro. Oral gavages of AAL-particles to naive BALB/c mice induced birch pollen-specific IgG2a, but not IgG1 antibodies. We conclude that targeting allergens to alpha-L-fucose-receptor bearing cells using AAL-microspheres induces specific Th1-antibody responses possibly counteracting Th2-dominated allergy, and therefore provides a potentially useful formulation for oral immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780716     DOI: 10.1016/j.vaccine.2004.11.052

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen.

Authors:  Douglas J Hanlon; Paulomi B Aldo; Lesley Devine; Ayesha B Alvero; Anna K Engberg; Richard Edelson; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2011-01-18       Impact factor: 3.886

Review 2.  Demystifying particle-based oral vaccines.

Authors:  Pedro Gonzalez-Cruz; Harvinder Singh Gill
Journal:  Expert Opin Drug Deliv       Date:  2021-07-06       Impact factor: 8.129

3.  Lectin-Grafted PLGA Microcarriers Loaded with Fluorescent Model Drugs: Characteristics, Release Profiles, and Cytoadhesion Studies.

Authors:  Xue-Yan Wang; Romana Koller; Michael Wirth; Franz Gabor
Journal:  Sci Pharm       Date:  2014-02-08

Review 4.  Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization.

Authors:  Carlos Gamazo; Nekane Martín-Arbella; Ana Brotons; Ana I Camacho; J M Irache
Journal:  Eur J Pharm Biopharm       Date:  2015-01-20       Impact factor: 5.571

5.  Targeting cell surface glycans with lectin-coated fluorescent nanodiamonds.

Authors:  Mina Ghanimi Fard; Zahra Khabir; Philipp Reineck; Nicole M Cordina; Hiroshi Abe; Takeshi Ohshima; Sagar Dalal; Brant C Gibson; Nicolle H Packer; Lindsay M Parker
Journal:  Nanoscale Adv       Date:  2022-02-07

Review 6.  Use of lectin-functionalized particles for oral immunotherapy.

Authors:  Susanne C Diesner; Xue-Yan Wang; Erika Jensen-Jarolim; Eva Untersmayr; Franz Gabor
Journal:  Ther Deliv       Date:  2012-02

7.  Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy.

Authors:  Susanne C Diesner; Cornelia Bergmayr; Xue-Yan Wang; Denise Heiden; Sarah Exenberger; Franziska Roth-Walter; Philipp Starkl; Davide Ret; Isabella Pali-Schöll; Franz Gabor; Eva Untersmayr
Journal:  Clin Immunol       Date:  2018-03-30       Impact factor: 3.969

Review 8.  Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting.

Authors:  Alice Gutjahr; Capucine Phelip; Anne-Line Coolen; Claire Monge; Anne-Sophie Boisgard; Stéphane Paul; Bernard Verrier
Journal:  Vaccines (Basel)       Date:  2016-10-12

Review 9.  Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon.

Authors:  Isabella Pali-Schöll; Douglas J DeBoer; Claudia Alessandri; Ahmed Adel Seida; Ralf S Mueller; Erika Jensen-Jarolim
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.